Tag: PATH

The project was galvanized by the acute shortage of medical oxygen in India during the second wave of Covid-19 and was supported by a grant of Rs.109 crore

Gavi's important decision enables low- and middle-income countries to consider adding RTS,S as an additional tool to combat malaria. Additional investments will be needed to expand vaccine supply if current demand projections are realized.......................

The PHC Tech Challenge is launched in partnership with the Office of the Principal Scientific Adviser to the Government of India, PATH, Centre for Cellular and Molecular Platform, Social Alpha, Swasth, ACT, Stanford Byers Centre for Biodesign, and The Stanford Centre for Innovation in Global Health..................

Bharat Biotech to produce antigen for world’s first vaccine against Plasmodium falciparum malaria following technology transfer, to help ensure long-term sustainable supply. Transfer builds on GSK commitments to donate up to 10 million vaccine doses.......................

To support the expansion of Covid-19 testing and contact tracing across India, The Rockefeller Foundation announced two new grants to The Center for Cellular and Molecular Platforms and PATH.....................

The two day global workshop aimed to discuss and finalize the candidate for International Reference Standard for Sabin Sabin Inactivated Polio vaccine is being organized by PATH with a grant supported by Gates Foundation on 11th and 12th July at Hyderabad...…………...

The agreement supports development and availability of an affordable, high-quality enzyme deficiency test.................

Having recently taken up the role of Director of Impact Lab at New Delhi based PATH India, Dr Satya Dash has now also joined the Board of Venture Center, Pune..............

The 4th HITLAB Innovators Summit held on February 10 at the Indian Institute of Technology, Delhi featured speakers from leading organizations including Johnson & Johnson, Stryker, IBM, PATH, Terumo, and more............................

ROTAVAC has been under development since the year 2000 necessitating investments of around USD 200 million towards product development and dedicated manufacturing infrastructure. The WHO approval will help in making it accessible and affordable.......